Alkeon Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $22.2M | Sell |
|
|||||
|
2023
Q1 | $18M | Sell |
|
|||||
|
2022
Q4 | $33.6M | Sell |
|
|||||
|
2022
Q3 | $33M | Sell |
|
|||||
|
2022
Q2 | $32M | Sell |
|
|||||
|
2022
Q1 | $59.4M | Sell |
|
|||||
|
2021
Q4 | $61.9M | Sell |
|
|||||
|
2021
Q3 | $92.2M | Buy |
|
|||||
|
2021
Q2 | $67.8M | Buy |
|
|||||
|
2021
Q1 | $24M | Hold |
|
|||||
|
2020
Q4 | $29M | Buy |
|